No Data
Buy Rating on Benitec Biopharma: Anticipating BB-301's Impact on OPMD Treatment and Stock Value
Leerink Partners Initiates Benitec Biopharma(BNTC.US) With Buy Rating, Announces Target Price $13
Leerink Partners analyst Mani Foroohar initiates coverage on $Benitec Biopharma(BNTC.US)$ with a buy rating, and sets the target price at $13.According to TipRanks data, the analyst has a success
Express News | Benitec Biopharma Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $13
Piper Sandler Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $30
Piper Sandler analyst Yasmeen Rahimi maintains $Benitec Biopharma(BNTC.US)$ with a buy rating, and maintains the target price at $30.According to TipRanks data, the analyst has a success rate of 38.9%
Analysts Are Bullish on These Healthcare Stocks: Madrigal Pharmaceuticals (MDGL), Benitec Biopharma (BNTC)
Benitec Biopharma Reports Promising Interim Study Results
No Data